Artificial Intelligence

New data suggests Phanes Therapeutics' bispecific antibody may overcome major side effects of CD47 inhibitors while showing promise in tough GI cancers.

FHFA's approval of VantageScore is igniting fierce competition, promising nearly $1B in savings and opening new paths to homeownership for millions.

CareCloud unveils its next-gen MAP App, blending AI with trusted HFMA benchmarks to help hospitals navigate complex financial challenges and boost efficiency.

Cingulate Inc. faces a critical FDA decision for its novel ADHD drug, but manufacturing queries and a tight cash runway create a high-stakes countdown.

Swiss firm H55's flight-proven batteries are fast-tracking a new hybrid-electric regional aircraft demonstrator, promising a 30% leap in fuel efficiency.

A new partnership merges cybersecurity and HR compliance, signaling a shift toward integrated, behavior-focused training to build more resilient work cultures.

Semiconductor firm Guerrilla RF is leveraging off-the-shelf parts to accelerate next-gen satellite tech, from military comms to direct-to-cell service.

A new US-Canadian partnership between UNION and NALAGX aims to use software-driven factories to solve the critical 155mm artillery shell shortage.

Mayfair High's new immersive lab promises a new era of career training, but it also highlights the high-stakes gamble of educational technology.

With its 20th straight #1 G2 award, FinQuery solidifies its leadership and signals a broader shift from manual tasks to AI-powered intelligent accounting.

A new partnership combines large-scale strategy with clinical AI tech, offering a single path for healthcare systems to deploy AI amid a global staff crisis.

Myseum launched an affiliate program for its Picture Party app, aiming to challenge social media giants with a privacy-first, algorithm-free model.

Artelo Biosciences is testing a novel cannabinoid drug for glaucoma, aiming to protect vision in a way current treatments can't—all without diluting shares.

A landmark deal between Australia's VVMF and UK's OXB aims to create a new cell and gene therapy manufacturing hub for the booming Asia-Pacific market.

A new AI platform promises to free skilled workers from administrative tasks, boosting efficiency and profit. Is this the future of the trades industry?

A new book by a neurologist, attorney, and MBA argues that five powerful systems are contributing to a crisis in children's neurodevelopment.

The AI cloud firm's upsized $4.0 billion convertible note offering signals strong investor confidence as it races to build out data centers for mega-clients.

A new partnership will leverage genetically engineered mice to create novel antibody drugs, potentially unlocking treatments for cancer and brain diseases.

New research shows AI tools are failing to curb alert fatigue, leaving enterprises exposed and raising new concerns about third-party data risks.

With a massive $68.7M seed round and novel T-cell engager tech, Shanghai's Excalipoint is pioneering a new model for rapid drug development.